Correction to: Considerations for Updates to ICH Q1 and Q5C Stability Guidelines: Embracing Current Technology and Risk Assessment Strategies Megan E. McMahonAlexander AbbottYan Wu Correction 15 November 2021 Article: 118
ICH Q10 Pharmaceutical Quality System Guidance: Understanding Its Impact on Pharmaceutical Quality Sean A. VanDuyseMichael J. FulfordMichael G. Bartlett Research Article 12 November 2021 Article: 117
Pharmacokinetics of Monoclonal Antibody and Antibody Fragments in the Mouse Eye Following Systemic Administration David BussingZhe LiDhaval K. Shah Research Article 08 November 2021 Article: 116
Immunogenicity Risk Assessment for Multi-specific Therapeutics Mark A. KroenkeMark N. MiltonJoleen T. White Review Article Open access 05 November 2021 Article: 115
Understanding Drug Delivery to the Brain Using Liposome-Based Strategies: Studies that Provide Mechanistic Insights Are Essential Firda JuhairiyahElizabeth C. M. de Lange Review Article Open access 28 October 2021 Article: 114
Understanding In Vivo Dissolution of Immediate Release (IR) Solid Oral Drug Products Containing Weak Acid BCS Class 2 (BCS Class 2a) Drugs Min LiXinwen ZhangLawrence Yu Research Article 26 October 2021 Article: 113
Understanding Quality Paradigm Shifts in the Evolving Pharmaceutical Landscape: Perspectives from the USP Quality Advisory Group Jane WeitzelHoracio PappaWesley Workman Commentary Open access 15 October 2021 Article: 112
A Systematic Approach for Liposome and Lipodisk Preclinical Formulation Development by Microfluidic Technology Elizabeth S. LevyJesse YuChun-Wan Yen Research Article 14 October 2021 Article: 111
Cluster Gauss–Newton and CellNOpt Parameter Estimation in a Small Protein Signaling Network of Vorinostat and Bortezomib Pharmacodynamics Jin NiuVan Anh NguyenDonald E. Mager Research Article 07 October 2021 Article: 110
Bioanalytical Challenges due to Prior Checkpoint Inhibitor Exposure: Interference and Mitigation in Drug Concentration and Immunogenicity Assays Andrew F. DenglerRachel WeissMichael A. Partridge Research Article Open access 04 October 2021 Article: 109
Evaluation of the Humoral Response to Adeno-Associated Virus-Based Gene Therapy Modalities Using Total Antibody Assays Boris GorovitsMitra AzadehBonnie Wu Review Article 16 September 2021 Article: 108
Considerations for Updates to ICH Q1 and Q5C Stability Guidelines: Embracing Current Technology and Risk Assessment Strategies Megan E. McMahonAlexander AbbottYan Wu Commentary 16 September 2021 Article: 107